Clovis Oncology, Inc.
CLVS
CLVS was delisted on the 20th of December, 2022.
192 hedge funds and large institutions have $3.28B invested in Clovis Oncology, Inc. in 2015 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 88 increasing their positions, 45 reducing their positions, and 25 closing their positions.
96% more repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 45
64% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 25
15% more capital invested
Capital invested by funds: $2.84B → $3.28B (+$439M)
8% more funds holding
Funds holding: 177 → 192 (+15)
0% more funds holding in top 10
Funds holding in top 10: 13 → 13 (0)
4% less call options, than puts
Call options by funds: $49.6M | Put options by funds: $51.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
Antipodean Advisors
New York
|
+$113M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
+$72.4M |
| 3 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$61.2M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$52.5M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$36.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
Cortland Advisers
Wilmington,
Delaware
|
-$72.7M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$50.3M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$25M |
| 4 |
CCM
Consonance Capital Management
New York
|
-$22.3M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$21.7M |
CLVS Hedge Fund Activity: Q3 2015 in Review
192 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Clovis Oncology, Inc. (CLVS) for Q3 2015, worth a combined $3.28B — up 15% from $2.84B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new CLVS positions and 25 closed out — a net gain of 16 holders — while 88 added to existing stakes and 45 trimmed.
The largest buyer was Antipodean Advisors, opening a new position worth an estimated $113M. The largest seller was Cortland Advisers, exiting entirely with an estimated $72.7M sold.
- 192 institutional investors held Clovis Oncology, Inc. (CLVS) as of Q3 2015, up from 177 in Q2 2015.
- Funds reported $3.28B of Clovis Oncology, Inc. stock for Q3 2015, up 15% quarter-over-quarter.
- 41 funds opened new Clovis Oncology, Inc. positions in Q3 2015 and 25 closed out, a net change of +16 holders.
- The largest Clovis Oncology, Inc. buyer in Q3 2015 was Antipodean Advisors, an estimated $113M added.
- The largest Clovis Oncology, Inc. seller in Q3 2015 was Cortland Advisers, an estimated $72.7M sold.
Based on aggregated 13F filings for Q3 2015.